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Abstract
T cell receptor (TCR) recognition of foreign peptide fragments, presented by peptide major 
histocompatibility complex (pMHC), governs T-cell mediated protection against pathogens and 
cancer. Many factors govern T-cell sensitivity, including the affinity of the TCR-pMHC interaction 
and the stability of pMHC on the surface of antigen presenting cells. These factors are particularly 
relevant for the peptide vaccination field, in which more stable pMHC interactions could enable 
more effective protection against disease. Here, we discuss a method for the determination of 
pMHC stability that we have used to investigate HIV immune escape, T-cell sensitivity to cancer 
antigens and mechanisms leading to autoimmunity.
Keywords
Peptide-MHC stability; Circular dichroism; Thermal stability; T-cells; Peptide vaccines; 
Recombinant protein; Protein folding
Background
The ability of CD8+ T-cells to respond to foreign invaders or dysregulated self is dependent 
on stable pMHC class I (pMHCI) presentation at the cell surface. Structurally, MHCI 
molecules form a peptide binding groove formed of two parallel α helices with a floor of β 
sheets at the interface between the α1 and α2 domains (Latron et al., 1992). The peptide 
binding groove has primary peptide binding pockets (B and F) that tightly interact with 
specific amino acids towards the N- and C-terminals of bound peptides. Although these 
pockets can accommodate a range of amino acids, they exhibit preferences for certain side 
chains that have been characterized using structural and biochemical approaches (Parker et 
al., 1992). This information has been used to generate so called ‘heteroclitic’ peptides in 
which natural peptides that have poor MHC-anchors can be modified with amino acids that 
bind optimally to MHC for vaccination (Cole et al., 2010). Moreover, pMHC stability has 
been linked to HIV immune escape (Bronke et al., 2013) and the selection of autoreactive T-
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cell clones (Yin et al., 2011). Thus, understanding the mechanisms that control pMHC 
stability are important for therapeutic design and understanding complex human diseases. 
Here, we developed a protocol to accurately determine pMHC stability using circular 
dichroism spectroscopy. We have used this technique, together with structural, biophysical 
and cellular experiments, to provide new insight into the molecular factors that determined 
T-cell antigen recognition in the context of a range of human diseases (Kløverpris et al., 
2015; Knight et al., 2015; Motozono et al., 2015; Cole et al., 2016; Jones et al., 2016; Cole 
et al., 2017).
Materials and Reagents
1. Cellulose nitrate 0.45 μm filter papers (Sartorius, catalog number: 11306-47-N)
2. 1.2 μm glass microfiber filters (GE Healthcare, catalog number: 1822-070)
3. 10 ml plastic syringes, Luer slip BD Plastipak (BD, catalog number: 302188)
4. 25 G needle (BD, catalog number: 300600)
5. 1 ml plastic syringes, Luer slip BD Plastipak (BD, catalog number: 303172)
6. 1.5 ml microcentrifuge tubes
7. Amicon centrifugal concentrating tubes 4 ml MWCO 10 kDa (Merck, catalog 
number: UFC801096)
8. Phosphate buffered saline (PBS) made up from Dulbecco A tablets (137 mM 
NaCl, 3 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.3) (Thermo Fisher 
Scientific, Thermo Scientific™, catalog number: BR0014G)
9. Ultrapure water (> 18 MΩ cm) for buffer preparations
10. Bolt® Bis-Tris 4-12% precast gels (Thermo Fisher Scientific, Invitrogen™, 
catalog number: NW04120BOX)
11. BlUeye prestained protein markers (Geneflow, catalog number: S6-0024)
12. Quick Coomassie Stain (Generon, catalog number: GEN-QC-STAIN-3L)
13. Ethanol absolute (200 Proof)
14. Nitric acid (HNO3), 70%
Equipment
1. Reusable bottle top filtration device (Thermo Fisher Scientific, Thermo 
Scientific™, catalog number: DS0320-5045)
2. Vacuum pump such as KNF Neuberger Vaccum Pump (KNF Neuberger, catalog 
number: 049268/018121)
3. 500 ml clear Duran bottles (Duran, catalog number: GL 45)
Fuller et al. Page 2









4. Liquid Chromatography system, with a 2 ml injection loop, and a fraction 
collector; we use the ÄKTA pure 25 L with a F9-R fraction collector (GE 
Healthcare, model: ÄKTA pure 25 L)
5. Size exclusion chromatography column; we use a Superdex 200 Increase 10/300 
GL column, bed volume 24 ml (GE Healthcare, catalog number: 28990944)
6. Benchtop refrigerated micro-centrifuge capable of 14,000 x g (e.g., Eppendorf, 
model: 5418 R)
7. Far-UV spectrophotometer with a bandwidth < 1.8 nm and quartz cuvettes. We 
use a single-beam Beckman DU 800 instrument with microcells that allow 
measurements with volumes of 50 to 100 μl (Beckman Coulter, model: DU® 
800)
8. A far-UV circular dichroism (CD) spectrometer with a temperature controlled 
cell holder. We use an AVIV Model 215 instrument (Aviv Biomedical, model: 
Aviv Model 215) with a single cell Peltier controlled cell holder, or make use of 
the Module B end-station spectrophotometer at the B23 Synchrotron Radiation 
CD (Diamond Light Source, model: B23) Beamline at the Diamond Light 
Source (Jávorfi et al., 2010; Cole et al., 2016). Alternative instruments are 
available from Applied Photophysics Ltd (Leatherhead, U.K.), JASCO Inc. 
(Easton, MD), and Olis Inc. (Bogart, GA)
9. Strain free sealable quartz cuvettes of appropriate path length fitting the CD 
instrument’s cell holder. We use Teflon stoppered Hellma Suprasil cells of 
various thickness, mostly 0.1-cm
10. A well-ventilated chemical fume hood should be accessible for cleaning cuvettes 
with HNO3
Software
1. An analysis software that can import the CD data files and allows curve fitting to 
a user defined set of equations is required. We use Origin version 7.5 and later 
(OriginLab Corp., Northampton, MA), but many other programs. e.g., Igor Pro, 
MATLAB, Micromath Scientist, SigmaPlot, etc. will work
Procedure
A. Purification and buffer exchange of pMHC protein
HLA-A2 and human β2-microglobulin (β2m) sequences were generated as 
described and cloned into separate pGMT7 expression plasmids (Cole et al., 
2007). Complexes of HLA-A2, β2m and peptides are refolded and purified as 
described (Bulek et al., 2012, MacLachlan et al., 2017) with the essential steps 
summarized below. For CD analysis, proteins should be of high purity and the 
preparation should lack the presence of denatured or incorrectly folded protein. 
In order to achieve this the proteins are purified on the day of, or the day before 
analysis, and stored on ice to avoid any freeze thaw cycles.
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1. Prepare a 500 ml solution of PBS using 1 tablet per 100 ml of ultra-pure 
water. With the bottle top filtration device and vacuum pump, filter this 
solution through a cellulose nitrate 0.45 μm filter paper, with a 1.2 μm 
glass microfiber filter as a pre-filter, into a 500 ml Duran bottle. Prepare 
another 500 ml Duran bottle of ultra-pure water.
2. Connect the gel filtration column to the ÄKTA FPLC system and wash 
with sterile ultra-pure water followed by equilibrating the system with 
PBS. Wash the 2 ml injection loop with ultra-pure water and equilibrate 
with PBS using a 10 ml syringe, taking special care to avoid the 
occurrence of any air gaps that can be transferred to the column.
3. Using a 25 G needle transfer the protein solution, of no more than 1 ml, 
into the injection loop using a 1 ml syringe avoiding any air bubbles.
4. Run the column at 0.5 ml/min and monitor elution by UV absorbance at 
280 nm (Note 1). Collect 1-ml fractions (the number of fractions 
depends on the elution profile, but we try and take 2-4 fractions from 
the center of the peak) and analyse by SDS-PAGE under reducing 
conditions to check for purity of the pMHC sample. We use 4-12% 
gradient Bolt® Bis-Tris gels, BLUeye prestained protein ladder, 
NuPAGE MES running buffer, and Quick Coomassie Stain.
5. Run a SDS-PAGE. Upon SDS-PAGE, pMHC dissociates into its 
constituent parts. Bands of HLA-A2 and β2m run at positions 
corresponding to ~32 and ~12 kDa, respectively. The peptide (~1 kDa) 
will run out of the gel (Figure 1).
6. Combine only the purest two or three fractions and concentrate using an 
Amicon centrifugal filtration tube with a MWCO of 10 kDa. This 
provides protein of adequate purity and concentration for CD analysis.
7. Directly before CD measurements, spin the samples at 14,000 x g for 
20 min at 4 °C usually without resulting in any visible pellet.
B. Determination of parameters
1. Record UV spectra of the supernatant (step A7) from 360 to 230 nm in 
a 1-cm quartz cuvette with the buffer baseline subtracted. Within the 
360 to 320 nm range, the absorbance should be essentially zero; any 
slope is due to light scattering indicating the presence of large 
aggregates.
2. Calculate the 280 nm absorption coefficient based on the amino acid 
composition (Pace et al., 1995) using the ProtParam website at http://
web.expasy.org/protparam/.
Due to the high amount of the aromatic residues Tyr (5.3%) and Trp 
(3.2%) within the HLA-A2 and β2-microglobulin sequences combined 
(see Supplements 1 and 2), a good estimate for  (absorption 
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coefficient) can be expected. As HLA-A2 and β2-microglobulin have 
two and one intra-chain disulphide bonds, respectively, the cystine 
contribution to the absorption is included (ProtParam option: ‘assuming 
all pairs of Cys residues form cystines’).
3. Calculate protein concentration from the measured optical density at 
280 nm  as:
(1)
4. Use ProtParam to calculate the molecular mass based on the average 
isotopic masses of amino acids. All three sequences of the HLA-A2/
β2m/peptide complex are entered into the program input field together. 
To account for the two missing peptide bonds due to the three instead of 
single chain complex as seen by the program, two times the molecular 
mass of water (2 x 18.02) is added to the resulting mass Mr.
5. Calculate the mean residue weight (MRW) required for the 
normalization of the CD data from this mass by dividing through the 
number of peptide bonds:
(2)
where, n is the number of amino acids within the trimer.
C. Data acquisition
1. Based on the concentration of the stock solution determined as 
described above, dilute an aliquot with buffer to result in ca. 600 μl of 
sample with c ~0.15 mg/ml (~3 μM), and record a further absorption 
spectrum to give the final protein concentration (Note 2).
2. Following the usual start-up procedure of the CD instrument (30 min 
flushing with N2 followed by a further 30 min period for stabilizing the 
xenon arc lamp), record a spectrum of the buffer (step A1) in a clean 
0.1-cm stoppered quartz cell from 260 to ~195 nm with the cell holder 
equilibrated to 4 °C. This spectrum is termed the baseline. We usually 
record spectra using a 1 nm bandwidth in 0.2 nm intervals with 3 or 4 
sec measuring time per data point resulting in ca. 20 to 25 min per 
spectrum (Note 3).
3. Record a further buffer baseline in the Kinetic Mode at a constant 
wavelength of 218 nm for 1 min in 2 sec intervals.
4. Clean the cell with water by rinsing, followed by rinsing with absolute 
ethanol and dried under a stream of nitrogen.
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5. Fill the same cell completely with the protein solution (~550 μl), closed 
tightly with a Teflon stopper avoiding trapping of an air bubble, and 
place into the CD cell holder in the same orientation as used for 
recording the baseline.
6. After ~2 min to allow for temperature equilibration, record the protein 
spectrum using the same instrument settings as used for the baseline. 
Data are reliable if the photomultiplier dynode voltage is < 500 V (Note 
4).
7. For temperature denaturation, set the wavelength to 218 nm (minimum 
in CD spectrum). Record changes in ellipticities in 0.5 °C intervals 
from 4 to ~80 °C using the following parameters: data collection 12 
sec/point; temperature equilibration 12 sec; temperature dead band 
0.3 °C; instrument heating rate 4 °C/min. During the intervals between 
data collection, the sample is shielded from the light beam by a closed 
slit. These settings result in an average heating rate of ~36 °C/h (Note 
5).
8. At elevated temperatures the HLA-A2/β2m/peptide complexes form 
large, visible aggregates (precipitation) that result in sharp changes of 
the melting profile and an increase of the dynode voltage indicating 
increased scattering. At this point, the measurement can be stopped.
9. Clean protein precipitate containing cuvettes thoroughly rinsing with 
water followed by filling with 70% HNO3 in a fume hood, incubation 
for 2 h to overnight, rinsing with water, ethanol, and drying with a 
stream of N2.
Data analysis
1. Import CD data files into the OriginLab software (Note 6).
2. For spectra analysis, subtract the buffer baseline. Normalise Θ values recorded in 
mdeg to molar ellipticities [Θ]MRW in the classical units (deg cm2 dmol-1) 
according:
(3)
with the concentration c in mg/ml and cell path length d in mm (Note 7).
3. Subtract the mean of Θ recorded at 218 nm in the Kinetic Mode (step C3) from 
the thermal melt ellipticities, and normalize to [Θ]MRW218nm according to Eq. 
(3).
4. Analysis of the thermal stability assumes a 2-state mechanism in which three 
unfolded polypeptide chains U combine to a native complex N:
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where, the equilibrium constant K is:
(5)
with a total chain concentration c0 = cU +3cN and a degree of conversion to the 
native state F = 3 cN/c0 (see e.g., Engel et al., 1977; Marky and Breslauer, 1987). 
The standard Gibbs free energy can be written as:
(6)
in which R is the gas constant (8.3145 J K-1 mol-1), ΔH0 the standard enthalpy, 
and ΔS0 the standard entropy. From Eqs. (5) and (6) it follows for the midpoint 
of transition, where F = 0.5 and T equals the melting temperature Tm, at which 
half of the proteins are in the folded and unfolded state, respectively, that
(7)
This means that in contrast to a single chain polypeptide the melting temperature 
is concentration dependent. Tm and ΔH0 can be obtained by fitting the entire 
transition curve to the van’t Hoff equation:
(8)
obtained by solving Eq. (7) for ΔS0 and substituting for ΔS0 in Eq. (6).
The molar ellipticities for the native and unfolded state [Θ]n and [Θ]u show an 
additional temperature dependence which in a first approximation can be 
assumed as linear:
(9)
where, [Θ]n0 and [Θ]u0 correspond to the [Θ] intercept at T = 0, and bn and bu 
describe the slopes of the native and unfolded states, respectively. The entire 
transition curve is thus described by:
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which is used for fitting with the Levenberg-Marquardt algorithm implemented 
in OriginLab. The essential parts of the fitting script are included as Supplement 
4.
5. As the HLA-A2/β2m/peptide complexes tend to precipitate within the transition 
region (step C8), we assume a common molar ellipticity [Θ]u0 = -4,500 deg cm2 
dmol-1 and slope bu = 0. For many temperature denatured proteins and model 
peptides [Θ]u0 values in the -4,000 to -5,000 deg cm2 dmol-1 range are observed 
(Venyaminov et al., 1993) (Notes 8 and 9).
6. Representative data
The general procedure to analyse the stability of a trimeric pMHC complex is 
illustrated using HLA-A2/β2m/ILAKFLHWL as an example (Figure 2).This 
complex has been analysed in detail (Cole et al., 2017) and the structure has been 
solved in complex with a TCR (Protein Data Bank entry 5MEN).
a. Absorption coefficient and mean-residue-weight are calculated by 
putting all three sequences (Supplements 1 to 3) into the input frame of 
ProtParam (step B2) resulting in:
Number of amino acids: 386
Molecular weight: 44820.03
.....
Extinction coefficients are in units of M-1 cm-1, at 
280 nm measured in water.
Ext. coefficient 101675
Abs 0.1% (=1 g/L) 2.269, assuming all pairs of Cys 
residues form cystines
b. The measured absorption of the protein solution (Figure 2A) shows 
 = 0.283 resulting with Eq. (1) in a concentration of 
0.283/2.269 = 0.125 mg/ml.
c. MRW is calculated according to Eq. (2) as MRW = (44,820.03 + 2 x 
18.02)/(386 - 3) = 117.12.
d. A CD buffer baseline and spectra of both solutions are recorded 
according to steps C2 to C6 using a 0.1-cm path length cuvette. 
Baselines were subtracted, and the spectrum is normalised according to 
Eq. (3) (Figure 2B). At 195 nm, the dynode voltage was ~500 V. This 
reflects the high absorbance of the chloride ion included in PBS. The 
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spectrum shows a minimum of [Θ]MRW = -8,950 deg cm2 dmol-1 at 218 
nm.
e. The melting curve is recorded as described in step C7 from 4 to 65 °C, 
the mean value of the baseline (step C3) is subtracted, and molar 
residue ellipticities calculated according to Eq. (3) (Figure 2C). Using 
the OriginLab script given as Supplement 4 fit the data according to Eq. 
(10). Values in the 59 to 65 °C range that show a pronounced deviation 
from a homogenous quasi-sigmoidal curve indicating protein 
aggregation (open dots in Figure 2C) were omitted from the fits. Fitting 
results in Tm = 54.5 ± 0.1 °C and ΔH0 = -500 ± 20 kJ/mol with a 
coefficient of determination r2 = 0.988.
Notes
1. Peak fractionation of the pMHC will occur at an elution volume of ~12 ml; it is 
important to keep only the purest fractions and discard any that contain protein 
from more than one peak.
2. To determine thermodynamic parameters, for HLA-A2/β2m/peptide complexes 
we aim for a concentration of ~0.15 mg/ml as for most peptides studied so far 
this can be relatively easily achieved and provides for a good signal-to-noise 
ratio to follow CD transition curves at 218 nm. Due to the concentration 
dependence of Tm for multi-chain proteins [Eq. (7)], it is important to settle for a 
narrow range to allow for comparison of data.
3. A cuvette can be regarded as optically clean if the baseline using PBS or water 
runs about parallel to a spectrum recorded without a cell in the light beam (‘air 
baseline’); minima observed in the 200 to 225 nm range usually indicate that 
protein from previous measurements is absorbed to the quartz surface.
4. On instruments of other manufacturers, the dynode voltage is called HT (high 
tension), and the reliable voltage range can differ depending on the type of 
photomultiplier and electronics.
5. The heating parameters have been tested to result in the set equilibrium 
temperatures by measuring with a Pt100 Resistance Temperature Detector inside 
a 0.1-cm cuvette.
6. The AVIV instrument software stores data in ASCII format. Some instruments 
from other manufacturers use propriety formats that require exporting into ASCII 
for analysis via other programs.
7. [Θ]MRW can be converted into molar absorption units Δε = εL - εR = [Θ]MRW/
3,298, where Δε is the absorption difference for left- and right-handed circularly 
polarized light.
8. From the various MHC complexes studied in our lab, HLA-A*0101/β2m/peptide 
VTEHDTLLY exhibit high stability both with respect to Tm (68.9 °C) and 
enthalpy (-719 kJ mol-1); precipitation occurred only at T > 72 °C, [Θ]U0 > 
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-5,200 deg cm2 dmol-1 (Jones et al., 2016). Using [Θ]U0 = -4,500 deg cm2 dmol-1 
resulted in a r2 > 0.996.
9. For strict thermodynamic analysis reversibility of the transition [Eq. (4)] is a 
prime requirement. It has been suggested, however, that even if reversibility is 
limited analysis is still of value as temperature induced cooperative unfolding is 
usually a much faster process than the aggregation of unfolded protein (Privalov, 
2009). To allow for comparison of data, we use the same heating parameters for 
all samples (see step C7).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SDS-PAGE analysis of pMHCI.
Approximately 20 μg of pMHCI (right lane) was loaded onto an 4-12% gradient Bolt® Bis-
Tris gel with 3 μl BLUeye prestained protein ladder (left lane) and run at 200 V for 23 min 
in NuPAGE MES running buffer. The gel was stained for 5 min in Quick Coomassie Stain 
and destained with ddH2O. The pMHCI α chain runs as a separate band at ~32 kDa and 
β2m at ~12 kDa.
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Figure 2. Thermal stability of HLA A2/β2m/ILKA.
A. Protein concentration is determined by UV absorbance spectroscopy. Wavelength scans 
from 360 to 230 nm are recorded in a 1-cm quartz cuvette using the same sample and buffer 
as used in subsequent CD measurements. Concentration is calculated assuming an 
absorbance coefficient  = 2.257 as calculated based on the amino acid composition. 
B. A far-UV CD spectrum was recorded in a 0.1-cm quartz cuvette at 4 °C and buffer 
baselines measured in the same cell using the same instrument parameters were subtracted. 
The signals were normalized to mean-residue-weight (MRW) ellipticities [Θ]MRW acc. Eq. 
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(3). C. Thermal stability was determined by following the ellipticity Θ at 218 nm upon 
increasing the temperature with measuring 12 sec per data point in ΔT = 0.5 °C intervals, an 
equilibration time of 12 sec between data points, a temperature dead band of ± 0.3 °C, and 
using slit closure between measurements resulting in a mean heating rate of 36 °C/h (red, 
left axis). The sample forms large, visible aggregates indicating precipitation in the 58 to 
65 °C range (open circles). Data points below this temperature (filled circles) were fitted 
acc. Eq. (10) resulting in the dashed curve. Aggregate formation is accompanied by 
increasing light scattering resulting in a steep increase of the dynode voltage (blue, right 
axis) followed by a decrease when large particles sink to the bottom of the cuvette.
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